enVVeno Medical Corporation
Save
61.20M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Specialties
Industry
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI.
Similar securities
Based on sector and market capitalization
Report issue